Focal facial dermal dysplasia
(Redirected from FFDD, type 1)
Focal Facial Dermal Dysplasia is a rare genetic disorder that affects the development of the facial dermis. It is characterized by bitemporal or preauricular skin lesions, apparent at birth or shortly thereafter. These lesions are typically hairless and scar-like, and may have associated pigmentation changes. Other features may include distichiasis (double row of eyelashes), partial or complete absence of the Meibomian glands, and/or absence of the lacrimal puncta.
Signs and Symptoms[edit | edit source]
The primary symptom of Focal Facial Dermal Dysplasia is the presence of bitemporal or preauricular skin lesions. These lesions are typically hairless and scar-like, and may have associated pigmentation changes. Other features may include distichiasis (double row of eyelashes), partial or complete absence of the Meibomian glands, and/or absence of the lacrimal puncta.
Causes[edit | edit source]
Focal Facial Dermal Dysplasia is a genetic disorder caused by mutations in the ADAM17 gene. This gene provides instructions for making a protein that is involved in the regulation of various cellular processes, including cell proliferation, cell differentiation, and apoptosis (programmed cell death).
Diagnosis[edit | edit source]
Diagnosis of Focal Facial Dermal Dysplasia is typically based on the clinical features and confirmed by genetic testing. Genetic testing can identify mutations in the ADAM17 gene, confirming the diagnosis.
Treatment[edit | edit source]
There is currently no cure for Focal Facial Dermal Dysplasia. Treatment is symptomatic and supportive, and may include surgical correction of the skin lesions and other associated features.
Prognosis[edit | edit source]
The prognosis for individuals with Focal Facial Dermal Dysplasia varies. The disorder does not typically affect lifespan, but the severity of symptoms can vary widely among affected individuals.
See Also[edit | edit source]
Focal facial dermal dysplasia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD